Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yolanda Hernandez Hernandez"'
Autor:
Nicolás Macías, Soledad Manzano Grossi, Silvia Caldés, Yolanda Hernandez Hernandez, Marian Goicoechea, Belen Ramirez Senent, Inés Aragoncillo Sauco, Covadonga Hevia, Yésika Amézquita
Publikováno v:
Journal of Nephrology. 34:763-771
Autologous arteriovenous fistula (AVF) is the best vascular access for hemodialysis. Distal forearm radiocephalic fistula is the best option, although the primary failure rate ranges from 20% to 50%. The main objective of the PHYSICALFAV trial was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::833151c1ea6965922b4a0aaf4ef593c9
https://doi.org/10.1007/s40620-020-00907-w
https://doi.org/10.1007/s40620-020-00907-w
Autor:
Angel Gallegos-Villalobos, Rocío Echarri Carrillo, Verónica Ruth Mercado Valdivia, Silvia Caldés Ruisánchez, Raquel Díaz Mancebo, Gabriel Ledesma Sánchez, Yesika Amézquita Orjuela, Yolanda Hernández Hernández, Covadonga Hevia Ojanguren, Antonio Cirugeda García
Publikováno v:
Nefrología (English Edition), Vol 44, Iss 5, Pp 747-749 (2024)
Externí odkaz:
https://doaj.org/article/190b1d9ce25d416d967141ac3fe5f649
Autor:
Angel Gallegos-Villalobos, Rocío Echarri Carrillo, Verónica Ruth Mercado Valdivia, Silvia Caldés Ruisánchez, Raquel Díaz Mancebo, Gabriel Ledesma Sánchez, Yesika Amézquita Orjuela, Yolanda Hernández Hernández, Covadonga Hevia Ojanguren, Antonio Cirugeda García
Publikováno v:
Nefrología, Vol 44, Iss 5, Pp 747-749 (2024)
Externí odkaz:
https://doaj.org/article/d92f1fe7333a4ba28441d80184c6d6a3
Autor:
Ines, Aragoncillo Sauco, Covadonga, Hevia, Soledad, Manzano Grossi, Yesika, Amezquita, Nicolas, Macias, Silvia, Caldes, Belen, Ramirez Senent, Yolanda, Hernandez Hernandez, Marian, Goicoechea, Beatriz, Sanchez Galan
Publikováno v:
Journal of nephrology. 34(3)
Autologous arteriovenous fistula (AVF) is the best vascular access for hemodialysis. Distal forearm radiocephalic fistula is the best option, although the primary failure rate ranges from 20% to 50%. The main objective of the PHYSICALFAV trial was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58e73ed818ff08e496c865364a4dbe5e
https://pubmed.ncbi.nlm.nih.gov/33387342
https://pubmed.ncbi.nlm.nih.gov/33387342
Autor:
Marian Goicoechea, Cristina Rabasco, Manuel Praga, Miguel Angel Frutos, Gema Maria Fernandez Juarez, Aniana Oliet, David Arroyo, Jara Caro, Lara Perea, Mario Espinosa, Elena Gutierrez-Solis, Natalia Ramos, Mónica Martín, Ana María Romera, Laura Fernández, Yolanda Hernandez Hernandez, Jorge Rojas-Rivera, Alfons Segarra, Javier Ocaña, Alfonso Valera, Irene Agraz
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 30(3)
Background Although tacrolimus is recommended by KDIGO Clinical Practice Guideline for Glomerulonephritis for the treatment of idiopathic membranous nephropathy (MN), little is known about factors that influence response and relapse of the disease af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bdc4eb9aecfa6b8e1a57fc42ff9690a
https://pubmed.ncbi.nlm.nih.gov/25274748
https://pubmed.ncbi.nlm.nih.gov/25274748